eMedicine Specialties > Dermatology > Reactive & Inflammatory Dermatoses

Balanitis Circumscripta Plasmacellularis: Follow-up

Author: Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Coauthor(s): George C Keough, MD, Chief, Clinical Assistant Professor, Department of Medicine, Dermatology Service, Eisenhower Army Medical Center; Daniel S Lehman, MD, Fellow in Minimally Invasive Urology/Oncology, Department of Urology, Columbia University Medical Center
Contributor Information and Disclosures

Updated: Mar 17, 2008

Follow-up

Prognosis

  • The prognosis is excellent if appropriate treatment is rendered.

Patient Education

Miscellaneous

Medicolegal Pitfalls

  • Failure to biopsy this lesion may lead to inappropriate medical or surgical therapy. This benign condition must be differentiated from penile carcinoma and erythroplasia of Queyrat to avoid overly aggressive therapy.
 


More on Balanitis Circumscripta Plasmacellularis

Overview: Balanitis Circumscripta Plasmacellularis
Differential Diagnoses & Workup: Balanitis Circumscripta Plasmacellularis
Treatment & Medication: Balanitis Circumscripta Plasmacellularis
Follow-up: Balanitis Circumscripta Plasmacellularis
References
[ CLOSE WINDOW ]

References

  1. Zoon JJ. [Chronic benign circumscript plasmocytic balanoposthitis.]. Dermatologica. 1952;105(1):1-7. [Medline].

  2. Mallon E, Hawkins D, Dinneen M, Francics N, Fearfield L, Newson R, et al. Circumcision and genital dermatoses. Arch Dermatol. Mar 2000;136(3):350-4. [Medline].

  3. Toker SC, Baskan EB, Tunali S, Yilmaz M, Karadogan SK. Zoon's balanitis in a circumcised man. J Am Acad Dermatol. Aug 2007;57(2 Suppl):S6-7. [Medline].

  4. Kumar B, Narang T, Dass Radotra B, Gupta S. Plasma cell balanitis: clinicopathologic study of 112 cases and treatment modalities. J Cutan Med Surg. Jan-Feb 2006;10(1):11-5. [Medline].

  5. Babu CS, Vitharana S, Higgins SP. Primary syphilis presenting as balanitis. Int J STD AIDS. Jul 2007;18(7):497-8. [Medline].

  6. Alessi E, Coggi A, Gianotti R. Review of 120 biopsies performed on the balanopreputial sac. from zoon's balanitisto the concept of a wider spectrum of inflammatory non-cicatricial balanoposthitis. Dermatology. 2004;208(2):120-4. [Medline].

  7. Weyers W, Ende Y, Schalla W, Diaz-Cascajo C. Balanitis of Zoon: a clinicopathologic study of 45 cases. Am J Dermatopathol. Dec 2002;24(6):459-67. [Medline].

  8. Hernandez-Machin B, Hernando LB, Marrero OB, Hernandez B. Plasma cell balanitis of Zoon treated successfully with topical tacrolimus. Clin Exp Dermatol. Sep 2005;30(5):588-9.

  9. Roé E, Dalmau J, Peramiquel L, Pérez M, López-Lozano HE, Alomar A. Plasma cell balanitis of zoon treated with topical tacrolimus 0.1%: report of three cases. J Eur Acad Dermatol Venereol. Feb 2007;21(2):284-5. [Medline].

  10. Moreno-Arias GA, Camps-Fresneda A, Llaberia C, Palou-Almerich J. Plasma cell balanitis treated with tacrolimus 0.1%. Br J Dermatol. Dec 2005;153(6):1204-6. [Medline].

  11. Virgili A, Mantovani L, Lauriola MM, Marzola A, Corazza M. Tacrolimus 0.1% Ointment: Is It Really Effective in Plasma Cell Vulvitis?. Report of Four Cases. Dermatology. Jan 9 2008;216(3):243-6. [Medline].

  12. Bardazzi F, Antonucci A, Savoia F, Balestri R. Two cases of Zoon's balanitis treated with pimecrolimus 1% cream. Int J Dermatol. Feb 2008;47(2):198-201. [Medline].

  13. Nasca MR, De Pasquale R, Micali G. Treatment of Zoon's balanitis with imiquimod 5% cream. J Drugs Dermatol. May 2007;6(5):532-4. [Medline].

  14. Petersen CS, Thomsen K. Fusidic acid cream in the treatment of plasma cell balanitis. J Am Acad Dermatol. Oct 1992;27(4):633-4. [Medline].

  15. Morioka S, Nakajima S, Yaguchi H, Naito K, Iwahara K, Ogawa H. Vulvitis circumscripta plasmacellularis treated successfully with interferon alpha. J Am Acad Dermatol. Nov 1988;19(5 Pt 2):947-50. [Medline].

  16. Ferrandiz C, Ribera M. Zoon's balanitis treated by circumcision. J Dermatol Surg Oncol. Aug 1984;10(8):622-5. [Medline].

  17. Kumar B, Sharma R, Rajagopalan M, Radotra BD. Plasma cell balanitis: clinical and histopathological features-- response to circumcision. Genitourin Med. Feb 1995;71(1):32-4. [Medline].

  18. Sonnex TS, Dawber RP, Ryan TJ, Ralfs IG. Zoon's (plasma-cell) balanitis: treatment by circumcision. Br J Dermatol. May 1982;106(5):585-8. [Medline].

  19. Baldwin HE, Geronemus RG. The treatment of Zoon's balanitis with the carbon dioxide laser. J Dermatol Surg Oncol. May 1989;15(5):491-4. [Medline].

  20. Retamar RA, Kien MC, Chouela EN. Zoon's balanitis: presentation of 15 patients, five treated with a carbon dioxidelaser. Int J Dermatol. Apr 2003;42(4):305-7. [Medline].

  21. Palminteri E, Berdondini E, Lazzeri M, Mirri F, Barbagli G. Resurfacing and reconstruction of the glans penis. Eur Urol. Sep 2007;52(3):893-8. [Medline].

  22. Davis DA, Cohen PR. Balanitis circumscripta plasmacellularis. J Urol. Feb 1995;153(2):424-6. [Medline].

  23. Davis-Daneshfar A, Trueb RM. Bowen's disease of the glans penis (erythroplasia of Queyrat) in plasma cell balanitis. Cutis. 2000;65:395-8. [Medline].

  24. English JC 3rd, Laws RA, Keough GC, Wilde JL, Foley JP, Elston DM. Dermatoses of the glans penis and prepuce. J Am Acad Dermatol. Jul 1997;37(1):1-24; quiz 25-6. [Medline].

  25. Erdogan BS, Demirkan N, Aktan S, Ergin S, Evliyaoglu D. A focus on differential diagnosis of lichen planus and plasma cell balanitis. J Eur Acad Dermatol Venereol. Jul 2006;20(6):746-8. [Medline].

  26. Houser ER, Gaston KE, Funkhouser WK, Israel B, Lavelle JP. Plasma cell (Zoon's) balanitis with concomitant HIV infection. Urology. Sep 2005;66(3):657. [Medline].

  27. Jolly BB, Krishnamurty S, Vaidyanathan S. Zoon's balanitis. Urol Int. 1993;50(3):182-4. [Medline].

  28. Kiene P, Folster-Holst R. No evidence of human papillomavirus infection in balanitis circumscripta plasmacellularis Zoon. Acta Derm Venereol. Nov 1995;75(6):496-7. [Medline].

  29. Kossard S, Shumack S. Lichen aureus of the glans penis as an expression of Zoon's balanitis. J Am Acad Dermatol. Oct 1989;21(4 Pt 1):804-6. [Medline].

  30. Murray WJ, Fletcher MS, Yates-Bell AJ, Pryor JP, Darby AJ, Packham DA. Plasma cell balinitis of Zoon. Br J Urol. Dec 1986;58(6):689-91. [Medline].

  31. Nishimura M, Matsuda T, Muto M, Hori Y. Balanitis of Zoon. Int J Dermatol. Jul-Aug 1990;29(6):421-3. [Medline].

  32. Ohta K, Horiguchi Y. Case of balanitis circumscripta plasmacellularis. J Dermatol. 2007 Apr;34(4):273-4. [Medline].

  33. Pastar Z, Rados J, Lipozencic J, Skerlev M, Loncaric D. Zoon plasma cell balanitis: an overview and role of histopathology. Acta Dermatovenerol Croat. 2004;12(4):268-73. [Medline].

  34. Souteyrand P, Wong E, MacDonald DM. Zoon's balanitis (balanitis circumscripta plasmacellularis). Br J Dermatol. Aug 1981;105(2):195-9. [Medline].

  35. Stern JK, Rosen T. Balanitis plasmacellularis circumscripta (Zoon's balanitis plasmacellularis). Cutis. Jan 1980;25(1):57-60. [Medline].

  36. Toonstra J, van Wichen DF. Immunohistochemical characterization of plasma cells in Zoon's balanoposthitis and (pre)malignant skin lesions. Dermatologica. 1986;172(2):77-81. [Medline].

  37. White JW Jr, Olsen KD, Banks PM. Plasma cell orificial mucositis. Report of a case and review of the literature. Arch Dermatol. Nov 1986;122(11):1321-4. [Medline].

  38. Yoganathan S, Bohl TG, Mason G. Plasma cell balanitis and vulvitis (of Zoon). A study of 10 cases. J Reprod Med. Dec 1994;39(12):939-44. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

plasma cell balanitis, Zoon balanitis,  plasma cell mucositis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Noah S Scheinfeld, MD, JD, FAAD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Optigenex Consulting fee Independent contractor

Coauthor(s)

George C Keough, MD, Chief, Clinical Assistant Professor, Department of Medicine, Dermatology Service, Eisenhower Army Medical Center
George C Keough, MD is a member of the following medical societies: American Academy of Dermatology and American Medical Association
Disclosure: Nothing to disclose.

Daniel S Lehman, MD, Fellow in Minimally Invasive Urology/Oncology, Department of Urology, Columbia University Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Janet Fairley, MD, Professor, Program Director, Section Chief, Department of Dermatology, Medical College of Wisconsin
Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Federation for Medical Research, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Rosalie Elenitsas, MD, Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System
Rosalie Elenitsas, MD is a member of the following medical societies: American Society of Dermatopathology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.